- Home
- SINT vs EPIX Comparison
SINT vs EPIX Comparison
Compare SINT & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- EPIX
- Stock Information
- Founded
- SINT 1996
- EPIX 2009
- Country
- SINT United States
- EPIX Canada
- Employees
- SINT N/A
- EPIX N/A
- Industry
- SINT Medical/Dental Instruments
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- EPIX Health Care
- Exchange
- SINT Nasdaq
- EPIX Nasdaq
- Market Cap
- SINT 8.3M
- EPIX 9.1M
- IPO Year
- SINT 2014
- EPIX N/A
- Fundamental
- Price
- SINT $3.93
- EPIX $0.20
- Analyst Decision
- SINT Strong Buy
- EPIX Hold
- Analyst Count
- SINT 1
- EPIX 3
- Target Price
- SINT $28.00
- EPIX $2.00
- AVG Volume (30 Days)
- SINT 2.2M
- EPIX 15.7M
- Earning Date
- SINT 11-11-2025
- EPIX 08-13-2025
- Dividend Yield
- SINT N/A
- EPIX N/A
- EPS Growth
- SINT N/A
- EPIX N/A
- EPS
- SINT N/A
- EPIX N/A
- Revenue
- SINT $1,861,000.00
- EPIX N/A
- Revenue This Year
- SINT N/A
- EPIX N/A
- Revenue Next Year
- SINT $87.50
- EPIX N/A
- P/E Ratio
- SINT N/A
- EPIX N/A
- Revenue Growth
- SINT N/A
- EPIX N/A
- 52 Week Low
- SINT $1.71
- EPIX $0.19
- 52 Week High
- SINT $8.60
- EPIX $7.41
- Technical
- Relative Strength Index (RSI)
- SINT 49.54
- EPIX 7.66
- Support Level
- SINT $4.20
- EPIX $0.19
- Resistance Level
- SINT $4.73
- EPIX $0.21
- Average True Range (ATR)
- SINT 0.69
- EPIX 0.02
- MACD
- SINT -0.10
- EPIX 0.02
- Stochastic Oscillator
- SINT 5.63
- EPIX 24.25
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.